News
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Although new medicines can help you lose weight faster and healthier than ever, a new psychology is needed to keep your ...
The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...
14h
Medpage Today on MSNGLP-1 Drugs May Hold Benefit in Painful Skin Disease
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...
Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results